These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6686539)

  • 1. Arrhythmia and prognosis in hypertrophic cardiomyopathy.
    McKenna WJ
    Eur Heart J; 1983 Nov; 4 Suppl F():225-34. PubMed ID: 6686539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy.
    McKenna WJ; Franklin RC; Nihoyannopoulos P; Robinson KC; Deanfield JE
    J Am Coll Cardiol; 1988 Jan; 11(1):147-53. PubMed ID: 3335690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis.
    McKenna WJ; England D; Doi YL; Deanfield JE; Oakley C; Goodwin JF
    Br Heart J; 1981 Aug; 46(2):168-72. PubMed ID: 7196768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR; Eisenberg R; Engel TR
    N Engl J Med; 1984 Jun; 310(24):1566-9. PubMed ID: 6539421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of arrhythmias in hypertrophic cardiomyopathy].
    Rapezzi C; Spirito P
    G Ital Cardiol; 1995 Nov; 25(11):1443-6. PubMed ID: 8682242
    [No Abstract]   [Full Text] [Related]  

  • 8. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ambulatory ECG in cardiomyopathies].
    Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
    G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death due to ventricular tachycardia during amiodarone therapy in familial hypertrophic cardiomyopathy.
    Gilligan DM; Missouris CG; Boyd MJ; Oakley CM
    Am J Cardiol; 1991 Oct; 68(9):971-3. PubMed ID: 1927963
    [No Abstract]   [Full Text] [Related]  

  • 11. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.
    McKenna WJ; Chetty S; Oakley CM; Goodwin JF
    Am J Cardiol; 1980 Jan; 45(1):1-5. PubMed ID: 6101296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.
    Savage DD; Seides SF; Maron BJ; Myers DJ; Epstein SE
    Circulation; 1979 May; 59(5):866-75. PubMed ID: 154981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D; Kubac G; Klinke WP
    Can J Cardiol; 1989 Mar; 5(2):77-80. PubMed ID: 2706577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
    Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.
    Kuck KH; Kunze KP; Schlüter M; Nienaber CA; Costard A
    Eur Heart J; 1988 Feb; 9(2):177-85. PubMed ID: 3280318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arrhythmias of primary hypertrophic cardiomyopathy].
    Babuty D; Fauchier L; Nguyen D; Giraudeau C; Marie O; Fauchier JP; Cosnay P
    Arch Mal Coeur Vaiss; 2003 Dec; 96 Spec No 7():7-15. PubMed ID: 15272516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients.
    Fananapazir L; Tracy CM; Leon MB; Winkler JB; Cannon RO; Bonow RO; Maron BJ; Epstein SE
    Circulation; 1989 Nov; 80(5):1259-68. PubMed ID: 2805263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
    Maron BJ; Savage DD; Wolfson JK; Epstein SE
    Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of arrhythmias in hypertrophic cardiomyopathy.
    Stewart JT; McKenna WJ
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):95-9. PubMed ID: 8086333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.